CT
LLY icon

Chicago Trust’s Eli Lilly LLY Stock Holding History

Chicago Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.46M Sell
7,888
-34
-0.4% -$34.7K 1.37% 14
2026
Q1 		$7.29M Sell
7,922
-213
-3% -$216K 1.16% 16
2025
Q4 		$8.74M Sell
8,135
-278
-3% -$266K 1.37% 13
2025
Q3 		$6.42M Sell
8,413
-142
-2% -$106K 0.89% 22
2025
Q2 		$6.67M Buy
8,555
+2,389
+39% +$1.86M 0.94% 21
2025
Q1 		$5.09M Sell
6,166
-84
-1% -$69.9K 0.9% 20
2024
Q4 		$4.83M Sell
6,250
-531
-8% -$440K 0.85% 21
2024
Q3 		$6.01M Buy
6,781
+392
+6% +$352K 1.04% 17
2024
Q2 		$5.78M Buy
6,389
+166
+3% +$133K 1.17% 16
2024
Q1 		$4.84M Buy
6,223
+500
+9% +$356K 1% 20
2023
Q4 		$3.34M Sell
5,723
-424
-7% -$247K 0.74% 28
2023
Q3 		$3.3M Buy
6,147
+71
+1% +$36.6K 0.83% 27
2023
Q2 		$2.85M Sell
6,076
-48
-0.8% -$20.1K 0.68% 34
2023
Q1 		$2.1M Buy
6,124
+21
+0.3% +$7.08K 0.53% 48
2022
Q4 		$2.23M Sell
6,103
-91
-1% -$32.3K 0.56% 48
2022
Q3 		$2M Sell
6,194
-422
-6% -$134K 0.52% 47
2022
Q2 		$2.15M Sell
6,616
-177
-3% -$53.1K 0.54% 50
2022
Q1 		$1.95M Sell
6,793
-239
-3% -$61.5K 0.42% 62
2021
Q4 		$1.94M Buy
7,032
+810
+13% +$205K 0.39% 70
2021
Q3 		$1.44M Buy
6,222
+450
+8% +$111K 0.32% 87
2021
Q2 		$1.32M Buy
5,772
+235
+4% +$47.2K 0.31% 93
2021
Q1 		$1.03M Sell
5,537
-259
-4% -$50.7K 0.36% 80
2020
Q4 		$978K Buy
5,796
+118
+2% +$17.6K 0.34% 87
2020
Q3 		$841K Buy
5,678
+1,123
+25% +$174K 0.35% 86
2020
Q2 		$747K Sell
4,555
-60
-1% -$9.21K 0.33% 89
2020
Q1 		$641K Sell
4,615
-45
-1% -$6.18K 0.32% 86
2019
Q4 		$612K Hold
4,660
– – 0.25% 101
2019
Q3 		$521K Sell
4,660
-18
-0.4% -$2K 0.22% 108
2019
Q2 		$519 Hold
4,678
– – 0.22% 108
2019
Q1 		$607 Sell
4,678
-130
-3% -$15.8K 0.26% 97
2018
Q4 		$556 Buy
4,808
+838
+21% +$93.6K 0.26% 97
2018
Q3 		$426K Buy
3,970
+25
+0.6% +$2.5K 0.17% 109
2018
Q2 		$337K Buy
3,945
+130
+3% +$10.7K 0.14% 119
2018
Q1 		$295K Buy
3,815
+375
+11% +$30.2K 0.13% 133
2017
Q4 		$290K Hold
3,440
– – 0.12% 132
2017
Q3 		$294 Sell
3,440
-100
-3% -$8.2K 0.12% 127
2017
Q2 		$291 Sell
3,540
-67
-2% -$5.47K 0.13% 121
2017
Q1 		$304 Buy
3,607
+192
+6% +$15.4K 0.13% 120
2016
Q4 		$251K Sell
3,415
-207
-6% -$15.4K 0.11% 129
2016
Q3 		$291K Sell
3,622
-500
-12% -$40K 0.13% 120
2016
Q2 		$324K Sell
4,122
-504
-11% -$37.9K 0.13% 122
2016
Q1 		$333K Sell
4,626
-300
-6% -$22.7K 0.14% 115
2015
Q4 		$415K Hold
4,926
– – 0.16% 112
2015
Q3 		$412K Sell
4,926
-200
-4% -$16.9K 0.16% 116
2015
Q2 		$428K Hold
5,126
– – 0.15% 117
2015
Q1 		$372K Buy
+5,126
New +$365K 0.13% 130

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Chicago Trust's LLY Position: Q2 2026 in Review

Chicago Trust reduced its Eli Lilly (LLY) stake by 0.43% in Q2 2026, selling an estimated $34.7K and leaving 7,888 shares worth $9.46M. The position accounts for 1.37% of the portfolio, ranked #14.

Chicago Trust first reported a position in LLY in Q1 2015 and has held it in 46 quarters since. 958 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chicago Trust held 7,888 shares of Eli Lilly worth $9.46M as of Q2 2026.
  • Chicago Trust sold 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 1.37% of Chicago Trust's portfolio in Q2 2026, its #14 holding.
  • Chicago Trust first reported a position in Eli Lilly in Q1 2015 and has held it in 46 quarters since.
  • 958 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.